Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Biobank & Sample Management Services

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract for Biobank and Sample Management Services supports the National Institutes of Health under the Gabriella Miller Kids First projects. The primary scope involves the collection, curation, and preparation of pediatric biological samples, specifically focusing on cohorts related to childhood cancer and congenital anomalies. The contractor is responsible for ensuring all samples are suitable for advanced genomic analyses, including whole genome, exome, transcriptome, and epigenome sequencing. Operational requirements include the use of cold chain storage and specialized DNA and RNA extraction kits to deliver high-quality, sequencing-ready materials. Because the work involves human subject research, strict adherence to IRB approvals is mandatory. The contract falls under NAICS code 541715 and is managed through the Department of Health and Human Services.

General Info

Subcontract for NIH pediatric biobank services, sample curation, and genomic sequencing preparation.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of PAR-27-071.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJan 20

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Performs collection, curation, and preparation of pediatric biological samples for prime contractors on NIH Gabriella Miller Kids First projects. Manages cohorts of childhood cancer and congenital anomaly samples, ensuring suitability for WGS, exome, transcriptome, and epigenome sequencing. Utilizes cold chain storage and DNA/RNA extraction kits. Requires IRB approvals for human subject research. Delivers high-quality, sequencing-ready biological samples.

Similar Contracts

Same NAICS industry code

Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination

Solicitation # HT9427-26-R-E020

Defense Health Agency

POSTED

about 12 hours ago

DEADLINE

MXO Office-wide Innovative Solutions Opening

Solicitation # DARPA-PS-26-115

The Defense Advanced Research Projects Agency (DARPA) Multi X Office (MXO) is seeking revolutionary research ideas through solicitation DARPA-PS-26-115. This long-term open call targets high-risk, high-reward technologies with a Technical Readiness Level (TRL) between 2 and 5, specifically focusing on beyond-CMOS foundational materials and components, indigenous development tools and supply chains, and new modalities for mission effects. The program explicitly excludes research that only provides evolutionary improvements to existing practices. Awards will be made to multiple proposers on a rolling basis using Other Transaction Agreements (OTAs) and Experimental Transaction Agreements (ETAs) under 10 U.S.C. sections 4021, 4022, and 4023. The submission process is conducted in two phases, beginning with a mandatory abstract submission via the Broad Agency Announcement Tool (BAAT). Abstracts are limited to six pages and must follow a specific template, with a final response deadline of June 4, 2027. Only invited proposers will be eligible to submit full proposals. Evaluation is based on the technical approach, potential contribution to U.S. national security, and budget realism. Key requirements include compliance with Cybersecurity Maturity Model Certification (CMMC) levels 1 or 2 depending on the use of Controlled Unclassified Information, and a risk-based security review for all senior and key personnel to identify undue foreign influence. All technical and administrative inquiries are directed to the MXO PS Coordinator.

Defense Advanced Research Projects Agcy

POSTED

about 12 hours ago

DEADLINE

NASA Research Announcement: V-Band

Solicitation # 80GRC027R0002

The NASA Glenn Research Center is soliciting information from potential sources to demonstrate V-band spectra cross-links among multiple satellites in a mesh network configuration. The objective is to validate multi-path routing and data delivery at rates suitable for NASA science and Earth remote sensing missions. Interested parties must provide capabilities statements detailing their ability to manage dynamic routing, characterize performance metrics such as throughput and latency, and validate technical reliability and cybersecurity through flight and ground demonstrations. This sources sought notice is intended for market research and planning purposes to determine competition levels and small business subcontracting goals. NASA is encouraging responses from all socioeconomic categories, including small businesses and minority institutions, to identify potential barriers to participation and strategies for increased inclusivity. All documentation and feedback must be submitted electronically to the designated contracting officers by October 6, 2026.

NASA Glenn Research Center

POSTED

about 12 hours ago

DEADLINE

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.

National Institutes Of Health

POSTED

about 20 hours ago

DEADLINE

STTR: Localization, Characterization, and Modeling of Freestream Disturbances in Hypersonic Wind Tunnels

Solicitation # DPA26TZ06-DV006

The Department of Defense, through the Small Business Projects Office, has issued solicitation DPA26TZ06-DV006 for a Small Business Technology Transfer project. The primary objective of this effort is to develop and demonstrate a robust methodology for localizing, characterizing, and modeling upstream noise and flow disturbances specifically within hypersonic wind tunnels. This opportunity is a total small business set-aside under the SBIR/STTR mandate for companies with fewer than 500 employees. Interested parties must submit their responses by October 21, 2026, following the posting date of September 23, 2026.

Small Business Projects Office

POSTED

about 20 hours ago

DEADLINE

SBIR: New World Screwworm Networked Detection, Identification, and Surveillance System

Solicitation # DPA26BZ06-DV024

The Department of Defense, through the Small Business Projects Office, is seeking proposals for the development of a networked surveillance system designed for the real-time detection and identification of the New World screwworm. This solicitation, identified as DPA26BZ06-DV024, focuses on creating automated technology to improve the accuracy and efficiency of monitoring these pests. This opportunity is a total small business set-aside under the SBIR/STTR mandate, limiting eligibility to firms with fewer than 500 employees. Interested parties must submit their responses by October 21, 2026, following the posting date of September 23, 2026.

Small Business Projects Office

POSTED

about 20 hours ago

DEADLINE

SBIR: Noninvasive Detection and Localization of Occult Hemorrhage

Solicitation # DPA26BZ06-DV025

The Department of Defense, through the Small Business Projects Office, is seeking a capability to noninvasively detect and localize occult non-compressible hemorrhage in environments outside of a hospital setting. This solicitation, identified as DPA26BZ06-DV025, aims to develop technology that can identify internal bleeding without the need for invasive procedures. This opportunity is a total small business set-aside under the SBIR/STTR mandate, restricted to companies with fewer than 500 employees. The solicitation was posted on September 23, 2026, and requires a response by the deadline of October 21, 2026.

Small Business Projects Office

POSTED

about 20 hours ago

DEADLINE

Signal Peptide Experimental ValidationThis subcontract, titled Signal Peptide Experimental Validation, is issued by Triad as a DOE contractor for the Department of Energy. The project involves performing laboratory testing to validate SignalGen predictions for prime contractors on biotechnology projects funded by the DOE. The scope of work includes synthesizing proteins with predicted signal peptides and expressing them in target organisms to verify secretion or cellular compartment localization. The performance of this contract takes place in Los Alamos, New Mexico, and requires the use of cell culture facilities and microscopy tools. The selected provider must maintain GLP and BSL certifications to deliver validation reports confirming the success of predicted signal peptides. The response deadline for this opportunity is March 22, 2027.

Triad - DOE Contractor

POSTED

DEADLINE

AI/LLM Model Integration and Bias Testing SpecialistThis subcontract for the Department of Veterans Affairs Technology Acquisition Center Nj focuses on the integration of Large Language Models into documentation systems for prime contractors working on procurement policy projects. The specialist will be responsible for developing an integrated AI module and governance reports, while implementing enterprise controls, content filters, and source citation and provenance features using AI benchmarking tools and LLM frameworks. A critical component of the role involves ensuring model integrity through bias evaluations using prompt pairs and benchmark scoring for accuracy. The contractor must provide detailed methodology documentation for bias testing to ensure the AI systems meet necessary standards. This opportunity was posted on September 22, 2026, with a response deadline of September 29, 2026, under NAICS code 541715.

Technology Acquisition Center Nj (36C10B)

POSTED

DEADLINE

Biomedical Research Facility/Lab AccessThis subcontract, titled Biomedical Research Facility/Lab Access, is issued by the Department of Health and Human Services under the Office of the Assistant Secretary for Administration. The agreement provides prime contractors on NIH-wide Global Doctoral Partnership projects with specialized laboratory space and technical facility access. This includes the delivery of physical research space and functional infrastructure designed to support basic, translational, or clinical biomedical research while maintaining strict institutional biosafety and ethics standards. The opportunity is categorized under NAICS code 541715 and was posted on September 22, 2026. Interested parties must submit their responses by the deadline of September 28, 2026, at 13:00. The contract ensures a compliant academic environment equipped with specialized biomedical laboratory equipment necessary for high-level scientific research.

Asa Office Of The Assistant Secretary For Administration

POSTED

DEADLINE

Commercial Operations Augmentation ServicesThe Commercial Operations Augmentation Services subcontract supports prime contractors on Mission Delta 9 projects for the Department of Defense, specifically under the FA2518 Ussf Spoc/saio agency. The primary objective is to fill critical capability gaps by implementing disruptive technologies, proprietary commercial platforms, and novel service models. This effort focuses on developing innovative approaches to meet mission objectives and delivering high-impact commercial technology solutions. The project is categorized under NAICS code 541715 and will be performed in Colorado Springs. Interested parties must note the response deadline of October 11, 2026, following the posting date of September 22, 2026.

FA2518 Ussf Spoc/saio

POSTED

DEADLINE

AI/ML Model Developer (Regulatory Analytics)This small business set-aside subcontract, titled AI/ML Model Developer (Regulatory Analytics), supports the FDA Office of Acquisitions and Grant Services within the Department of Health and Human Services. The project focuses on the development and deployment of advanced AI and machine learning models, specifically utilizing large language models, natural language processing, and generative AI. Key deliverables include AI-powered signal detection for FAERS, predictive models for regulatory outcomes, and the creation of digital twins to simulate regulatory processes. The contract requires the delivery of trained machine learning models, signal detection algorithms, and process simulation software. Performance will take place in Silver Spring, Maryland, under NAICS code 541715. The solicitation was posted on September 22, 2026, with a response deadline of September 28, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesThe National Institute of Neurological Disorders and Stroke, in collaboration with other NIH entities, is forecasting support for research projects aimed at enhancing biomedical and behavioral rigor, replicability, and reproducibility. Key areas of interest include assessing the scientific impact of these improvements, creating frameworks for selecting high-value replication studies, and measuring the robustness and generalizability of research findings to drive scientific innovation. This notice serves as a forecast to allow potential applicants to establish collaborations and develop responsive projects, as formal applications are not currently being solicited. Interested parties can contact the NINDS Office of Research Quality for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)The National Institutes of Health, through the National Institute of Mental Health, is issuing a forecast for a Notice of Funding Opportunity titled Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs). This initiative aims to establish a research network to evaluate the clinical effectiveness, safety, and durability of rapid-acting treatments such as ketamine, esketamine, and psilocybin for individuals with serious mental illnesses. The primary objective is to generate actionable real-world evidence to determine how these interventions can be safely and sustainably integrated into routine clinical practice across diverse patient populations and healthcare settings. By addressing current gaps in knowledge regarding implementation and long-term benefits, the project seeks to inform future healthcare delivery strategies for emerging psychotropic treatments.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Emerging Global Leader Award (K43)The Emerging Global Leader Award (K43), issued by the National Institutes of Health under the Department of Health and Human Services, provides salary and research support to junior faculty and research scientists based at academic or research institutions in Low- and Middle-Income Countries. The program focuses on biomedical, behavioral, and clinical research that leverages unique opportunities in these regions to create generalizable knowledge benefiting both U.S. and international populations. Recipients must engage in intensive mentored research and career development guided by senior researchers from both the U.S. and their respective home countries. By leveraging existing NIH research investments, the initiative aims to develop global research leaders who can mentor future investigators and strengthen international research networks.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Single Source: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)The National Institute of Mental Health intends to issue a single-source cooperative agreement to the University of California, Santa Cruz, to renew the Data Resource and Administrative Coordination Center within the SSPsyGene Consortium. The primary objective is to study how risk genes for neurodevelopmental and psychiatric disorders influence biological systems across molecular, cellular, and organismal levels. The renewed center will focus on creating a sustainable, interoperable knowledge base with standardized data terms to facilitate the use of artificial intelligence in accelerating brain function research for the broader biomedical community. This opportunity is currently listed as a forecast for a single source Notice of Funding Opportunity. While the award is intended for a specific institution, applications will still undergo the standard NIH peer-review process to ensure only meritorious projects are funded. The initiative emphasizes the harmonization of data from Assay and Data Generation Centers and the improvement of submission processes to data archives.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth)The National Institutes of Health, through the Fogarty International Center, is seeking to establish hubs of interdisciplinary research and training via the Global Environmental and Occupational Health program. This initiative focuses on fostering collaborations between scientists in the United States and low- and middle-income countries to study environmental and chemical exposures and their impacts on health. The program requires a dual approach that integrates scientific research with complementary research training to inform the detection, prevention, and intervention of diseases and disabilities related to occupational and environmental health. Projects must address health priorities relevant to both the United States and participating low- and middle-income countries while aligning with the mission of participating NIH institutes. A key objective is to accelerate scientific advancement through the widespread sharing of data and resources, providing critical opportunities for graduate students, postdoctoral researchers, and early-career investigators. Ultimately, these awards aim to strengthen international research networks and develop evidence-based strategies to protect public health and enhance resilience globally.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)The National Institutes of Health, through the Office of Research Infrastructure Programs, is seeking innovative research to develop, characterize, and improve research models, biological materials, and new approach methodologies relevant to human health and diseases. The funding opportunity focuses on enhancing the identification and control of confounding factors in biomedical research and requires that proposed projects have broad applicability across multiple NIH Institutes or Centers. To be eligible, proposed studies must incorporate research models or new approach methodologies that explore multiple body systems or various categories of diseases. Applications that are limited to a single disease, a narrow research area, or a single body system, or those primarily relevant to only one NIH Institute, will be deemed unacceptable. This forecast is listed under the Department of Health and Human Services and does not allow for clinical trials.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Technology Development ProgramThe Technology Development Program, administered by the National Institutes of Health under the Department of Health and Human Services, is a forecast funding opportunity designed to support technology research projects ranging from proof-of-concept to prototype development. The program specifically prioritizes innovation over feasibility to drive significant advancements in future biomedical research. To qualify for support, projects must focus exclusively on technological advances. Proposals that include tests of biological hypotheses or specific biomedical aims are not eligible. Interested parties can contact the NIGMS Technology Development office for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Limited Competition: Tribal Undergraduate and Graduate Research Training and Leadership Experiences (TURTLE) ProgramThe Tribal Undergraduate and Graduate Research Training and Leadership Experiences (TURTLE) Program, administered by the National Institutes of Health under the Department of Health and Human Services, provides phased awards to eligible Tribal Entities. The program is designed to cultivate a skilled pool of students capable of conducting Tribal health research, completing biomedical degrees, and successfully transitioning into the professional biomedical research workforce. This opportunity is a forecast for a limited competition, meaning only invited eligible organizations may apply. Selected applicants will undergo a standard NIH peer-review process to ensure only meritorious applications are funded. The program focuses on developing and implementing comprehensive training and mentoring activities for individuals pursuing baccalaureate or doctoral degrees in biomedical research fields across the United States and its territories.

Colleges, Universities, and Professional Schools

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, is issuing a forecast for Stage 2 of the Somatic Mosaicism across Human Tissues (SMaHT) Genome Characterization Centers initiative. Building upon the multi-omic datasets established in Stage 1, this program aims to advance the understanding of biological processes and disease mechanisms driven by somatic mutations across various human tissues. The primary objective of the Stage 2 centers is to determine the functional consequences of somatic mutations within both healthy and clinically relevant tissue samples, specifically focusing on patients whose phenotypes are suspected to be driven by these mutations. This effort is designed to further characterize somatic mosaicism and its broader role in human biology and disease.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, is issuing a forecast for the Somatic Mosaicism across Human Tissues (SMaHT) Program focusing on Experimental and Computational Technology Development. This initiative aims to advance the understanding of biological processes and disease mechanisms by developing, optimizing, and validating cost-effective technologies for somatic mutation detection and functional interpretation. Building upon the multi-omic datasets established in Stage 1, this second stage emphasizes the creation of rigorous benchmarks and the dissemination of tools to support the discovery of mutations across human tissues. Awardees will be expected to work collaboratively with other SMaHT Stage 2 initiatives to integrate these validated technologies into production workflows, data releases, and broader community resources. This multidisciplinary effort is designed to enhance the detection and analysis of somatic mutations across all three germ layers. Interested parties can contact the SMaHT Program via email for further information regarding this opportunity.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)The National Institutes of Health, under the Department of Health and Human Services, is offering a funding opportunity titled Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility. This forecast focuses on supporting mechanistic research to determine how exposure to metals and metal-containing compounds affects biological processes related to human health. Priority is given to studies exploring the absorption, distribution, transport, and mechanisms of action of metals, specifically regarding their impact on immune homeostasis, the central nervous system, and the placental barrier. Eligible research may utilize human biospecimens, computational approaches, experimental models, or new approach methodologies to test defined mechanistic hypotheses. This specific opportunity does not allow for clinical trials. Interested parties can find further details through the provided grants.gov link or by contacting the designated point of contact.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS